Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate.
D000328:Adult; D003692:Delayed-Action Preparations / Q000627:therapeutic use*; D003863:Depression / Q000150:complications / Q000188:drug therapy; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005476:Fluphenazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D008297:Male; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy
D003692:Delayed-Action Preparations; C011825:fluphenazine depot; D007099:Imipramine; D005476:Fluphenazine